JOURNEY AS AN ORTHOPAEDIC SURGEON, RESEARCHER, SURGICAL SITE INFECTION CONTROL & BONE LOSS EXPERT Associate Professor Kevin Tetsworth, Orthopaedic Surgeon
As an orthopaedic surgeon, Associate Professor Kevin Tetsworth, is widely recognised for his expertise in managing orthopaedic infections, chronic osteomyelitis, limb salvage, and reconstruction. He holds clinical appointments at the Royal Brisbane and Women’s Hospital, the Wesley Hospital in Brisbane, Macquarie University in Sydney at the Limb Reconstruction Centre.
His credentials encompass a fellowship in the American Academy, a fellowship in the Royal College in Australia, and membership in the Australian Orthopaedic Association and the International Orthopaedic Trauma Association. Associate Professor Tetsworth’s clinical focus revolves around the comprehensive management of orthopaedic infections, segmental bone defects, high-energy trauma, limb salvage and reconstruction, deformity correction, limb lengthening, and prosthetic joint infections.
In tandem with his clinical practice, Associate Professor Tetsworth is deeply engaged in orthopaedic research, with a keen interest in infection management, infection control, limb salvage, bone defect reconstruction, biomarker development for infection, bone growth hormone delivery, and the use of 3D printed models for reconstructing segmental bone defects.
His professional journey has been profoundly shaped by training under esteemed mentors like Professor Dror Paley and Dr George Cierny in the United States. This formative training has equipped him with a high level of expertise in addressing complex orthopaedic conditions, particularly those related to bone loss and infection. Having practiced in the United States, notably at the University of Maryland and the shock trauma hospital in Baltimore, Associate Professor Tetsworth relocated to Australia in 2000 and has since played a pivotal role in advancing orthopaedic surgery at the Royal Brisbane Hospital.
Associate Professor Tetsworth’s unwavering commitment to advancing orthopaedic knowledge and his exceptional proficiency in managing challenging orthopaedic conditions have earned him widespread recognition within the field.
In this Australian Health Journal interview, Assoc Professor Tetsworth talks about his clinical and research career journey and gives advice for those in medicine considering a career in orthopaedic surgery,
Assoc Prof Tetsworth concludes with a discussion on ways infection control is handled in preoperative, intraoperative and post operatively for orthopaedic surgeries.
He discusses the techniques started in the 19th century with understanding of hand hygiene, surgical instruments being sterilised and discovery of antibiotics in the 20th century, to present day practises of patient modifiable factors such as prescreening patients, lifestyle adjustments such as BMI or weight management, checking HbA1c levels for those who are diabetic and use of triclosan coated sutures in wound dressing in the early post operative period.
-
Integrating oral health care across non-dental professionals
Poor oral health can contribute to or exacerbate several systemic health conditions due to the close connection between oral bacteria, inflammation, and systemic processes. These conditions include cardiovascular health, diabetes, respiratory health, cognitive health, pregnancy and birth outcomes.
-
Gaining a better understanding of perimenopause and menopause
Nearly half of women seeking help for menopause symptoms are already experiencing clinically significant distress by the time they ask for support, according to a recent national benchmark report released by Metluma.
The 2026 Australian Menopause Experience Report, based on insights from 1,468 women using Metluma’s UMA40 assessment tool, found 43% triggered at least one clinical red flag at baseline (referral to a doctor within 24-48 hours), with more than one in five presenting with multiple red flags linked to more complex symptom burden.
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
